Literature DB >> 23933758

Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation.

H Nakasone1, M Onizuka, N Suzuki, N Fujii, S Taniguchi, K Kakihana, H Ogawa, K Miyamura, T Eto, H Sakamaki, H Yabe, Y Morishima, K Kato, R Suzuki, T Fukuda.   

Abstract

Cryptogenic organizing pneumonia (COP), previously known as bronchiolitis obliterans organizing pneumonia (BOOP), is a significant complication after allogeneic hematopoietic SCT (HCT). However, the pathogenesis of this complication has not yet been elucidated. Therefore, we identified the pre-transplant risk factors for the development of COP/BOOP using the Japan transplant registry database between 2005 and 2009. Among 9550 eligible recipients, 193 experienced COP/BOOP (2%). HLA disparity (odds ratio (OR) 1.51, P=0.05), female-to-male HCT (OR 1.53, P=0.023), and PBSC transplant (OR 1.84, P=0.0076) were significantly associated with an increased risk of COP/BOOP. On the other hand, BU-based myeloablative conditioning (OR 0.52, P=0.033), or fludarabine-based reduced-intensity conditioning (OR 0.50, P=0.0011) in comparison with a TBI-based regimen and in vivo T-cell depletion (OR 0.46, P=0.055) were associated with a lower risk. Of the 193 patients with COP/BOOP, 77 died, including non-relapse death in 46 (59%). Pulmonary failure and fatal infection accounted for 41% (n=19) and 26% (n=12) of the non-relapse death. Allogeneic immunity and conditioning toxicity could be associated with COP/BOOP. Prospective studies are required to elucidate the true risk factors for COP/BOOP and to develop a prophylactic approach.

Entities:  

Mesh:

Year:  2013        PMID: 23933758     DOI: 10.1038/bmt.2013.116

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  12 in total

1.  Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Bianca Harris; Sejal M Morjaria; Eric R Littmann; Alexander I Geyer; Diane E Stover; Juliet N Barker; Sergio A Giralt; Ying Taur; Eric G Pamer
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

2.  A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.

Authors:  Sabarinath Venniyil Radhakrishnan; Gerhard C Hildebrandt
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

Review 3.  Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

Authors:  Hideki Nakasone; Bita Sahaf; David B Miklos
Journal:  Int J Hematol       Date:  2015-03-27       Impact factor: 2.490

4.  Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation.

Authors:  Yasuko Kajimura; Yukinori Nakamura; Tsunahiko Hirano; Yoshinori Tanaka; Kaoru Yamamoto; Yoshihiro Tokunaga; Takahiro Sasaki; Keiji Oishi; Toshiaki Yujiri; Kazuto Matsunaga; Yukio Tanizawa
Journal:  Ann Hematol       Date:  2022-05-23       Impact factor: 4.030

5.  Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Sagar S Patel; Kwang Woo Ahn; Manoj Khanal; Caitrin Bupp; Mariam Allbee-Johnson; Navneet S Majhail; Betty K Hamilton; Seth J Rotz; Hasan Hashem; Amer Beitinjaneh; Hillard M Lazarus; Maxwell M Krem; Tim Prestidge; Neel S Bhatt; Akshay Sharma; Shahinaz M Gadalla; Hemant S Murthy; Larisa Broglie; Taiga Nishihori; César O Freytes; Gerhard C Hildebrandt; Usama Gergis; Sachiko Seo; Baldeep Wirk; Marcelo C Pasquini; Bipin N Savani; Mohamed L Sorror; Edward A Stadtmauer; Saurabh Chhabra
Journal:  Transplant Cell Ther       Date:  2022-03-18

6.  Machine Learning Algorithms to Differentiate Among Pulmonary Complications After Hematopoietic Cell Transplant.

Authors:  Husham Sharifi; Yu Kuang Lai; Henry Guo; Mita Hoppenfeld; Zachary D Guenther; Laura Johnston; Theresa Brondstetter; Laveena Chhatwani; Mark R Nicolls; Joe L Hsu
Journal:  Chest       Date:  2020-04-25       Impact factor: 10.262

Review 7.  A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.

Authors:  Lama Elbahlawan; Ashok Srinivasan; R Ray Morrison
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-25       Impact factor: 5.742

8.  Cytomegalovirus pneumonitis complicated by a central peribronchial pattern of organising pneumonia.

Authors:  Maria M Cuadrado; Asia Ahmed; Ben Carpenter; Jeremy S Brown
Journal:  Respir Med Case Rep       Date:  2017-02-20

Review 9.  Late effects of blood and marrow transplantation.

Authors:  Yoshihiro Inamoto; Stephanie J Lee
Journal:  Haematologica       Date:  2017-02-23       Impact factor: 9.941

Review 10.  Respiratory failure in the hematopoietic stem cell transplant recipient.

Authors:  Patrick M Wieruszewski; Svetlana Herasevich; Ognjen Gajic; Hemang Yadav
Journal:  World J Crit Care Med       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.